Literature DB >> 29888960

Gene expression profiling of breast cancer cell lines treated with proton and electron radiations.

Valentina Bravatà1, Luigi Minafra1, Francesco Paolo Cammarata1, Pietro Pisciotta1,2,3, Debora Lamia1, Valentina Marchese2, Giada Petringa2, Lorenzo Manti4, Giuseppe Ap Cirrone2, Maria Carla Gilardi1,5, Giacomo Cuttone2, Giusi Irma Forte1, Giorgio Russo1,2.   

Abstract

OBJECTIVE: Technological advances in radiation therapy are evolving with the use of hadrons, such as protons, indicated for tumors where conventional radiotherapy does not give significant advantages or for tumors located in sensitive regions, which need the maximum of dose-saving of the surrounding healthy tissues. The genomic response to conventional and non-conventional linear energy transfer exposure is a poor investigated topic and became an issue of radiobiological interest. The aim of this work was to analyze and compare molecular responses in term of gene expression profiles, induced by electron and proton irradiation in breast cancer cell lines.
METHODS: We studied the gene expression profiling differences by cDNA microarray activated in response to electron and proton irradiation with different linear energy transfer values, among three breast cell lines (the tumorigenic MCF7 and MDA-MB-231 and the non-tumorigenic MCF10A), exposed to the same sublethal dose of 9 Gy.
RESULTS: Gene expression profiling pathway analyses showed the activation of different signaling and molecular networks in a cell line and radiation type-dependent manner. MCF10A and MDA-MB-231 cell lines were found to induce factors and pathways involved in the immunological process control.
CONCLUSION: Here, we describe in a detailed way the gene expression profiling and pathways activated after electron and proton irradiation in breast cancer cells. Summarizing, although specific pathways are activated in a radiation type-dependent manner, each cell line activates overall similar molecular networks in response to both these two types of ionizing radiation. Advances in knowledge: In the era of personalized medicine and breast cancer target-directed intervention, we trust that this study could drive radiation therapy towards personalized treatments, evaluating possible combined treatments, based on the molecular characterization.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29888960      PMCID: PMC6223146          DOI: 10.1259/bjr.20170934

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  48 in total

1.  Proteomics and pathway analysis identifies JNK signaling as critical for high linear energy transfer radiation-induced apoptosis in non-small lung cancer cells.

Authors:  Sara Ståhl; Eva Fung; Christopher Adams; Johan Lengqvist; Birgitta Mörk; Bo Stenerlöw; Rolf Lewensohn; Janne Lehtiö; Roman Zubarev; Kristina Viktorsson
Journal:  Mol Cell Proteomics       Date:  2009-01-23       Impact factor: 5.911

Review 2.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

Review 3.  Novel applications of proton therapy in breast carcinoma.

Authors:  John J Cuaron; Shannon M MacDonald; Oren Cahlon
Journal:  Chin Clin Oncol       Date:  2016-08

4.  Gene Expression Profiling of MCF10A Breast Epithelial Cells Exposed to IOERT.

Authors:  Luigi Minafra; Valentina Bravatà; Giorgio Russo; Giusi Irma Forte; Francesco Paolo Cammarata; Marilena Ripamonti; Giuliana Candiano; Melchiorre Cervello; Agata Giallongo; Giovanni Perconti; Cristina Messa; Maria Carla Gilardi
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

Review 5.  The calpain family and human disease.

Authors:  Y Huang; K K Wang
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

6.  Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line.

Authors:  Kristina Viktorsson; Jessica Ekedahl; Maria C Lindebro; Rolf Lewensohn; Boris Zhivotovsky; Stig Linder; Maria C Shoshan
Journal:  Exp Cell Res       Date:  2003-10-01       Impact factor: 3.905

7.  Kirrel2, a novel immunoglobulin superfamily gene expressed primarily in beta cells of the pancreatic islets.

Authors:  Chao Sun; Daniel Kilburn; Alex Lukashin; Thomas Crowell; Humphrey Gardner; Ralf Brundiers; Beate Diefenbach; John P Carulli
Journal:  Genomics       Date:  2003-08       Impact factor: 5.736

8.  Radiation Gene-expression Signatures in Primary Breast Cancer Cells.

Authors:  Luigi Minafra; Valentina Bravatà; Francesco P Cammarata; Giorgio Russo; Maria C Gilardi; Giusi I Forte
Journal:  Anticancer Res       Date:  2018-05       Impact factor: 2.480

9.  Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

Authors:  Xu Li; Wenqi Wang; Jiadong Wang; Anna Malovannaya; Yuanxin Xi; Wei Li; Rudy Guerra; David H Hawke; Jun Qin; Junjie Chen
Journal:  Mol Syst Biol       Date:  2015-01-21       Impact factor: 11.429

10.  Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo - GEANT4 and experimental study.

Authors:  Giorgio Russo; Carlo Casarino; Gaetano Arnetta; Giuliana Candiano; Alessandro Stefano; Filippo Alongi; Giovanni Borasi; Cristina Messa; Maria C Gilardi
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102

View more
  4 in total

1.  Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.

Authors:  Francesco P Cammarata; Filippo Torrisi; Giusi I Forte; Luigi Minafra; Valentina Bravatà; Pietro Pisciotta; Gaetano Savoca; Marco Calvaruso; Giada Petringa; Giuseppe A P Cirrone; Anna L Fallacara; Laura Maccari; Maurizio Botta; Silvia Schenone; Rosalba Parenti; Giacomo Cuttone; Giorgio Russo
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

2.  Hypoxia Transcriptomic Modifications Induced by Proton Irradiation in U87 Glioblastoma Multiforme Cell Line.

Authors:  Valentina Bravatà; Walter Tinganelli; Francesco P Cammarata; Luigi Minafra; Marco Calvaruso; Olga Sokol; Giada Petringa; Giuseppe A P Cirrone; Emanuele Scifoni; Giusi I Forte; Giorgio Russo
Journal:  J Pers Med       Date:  2021-04-16

3.  The Role of Radiation in Cancer Treatment: New Insights towards Personalized Therapies.

Authors:  Luigi Minafra; Francesco P Cammarata; Marco Calvaruso
Journal:  J Pers Med       Date:  2022-02-19

Review 4.  Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

Authors:  Marika Musielak; Wiktoria M Suchorska; Magdalena Fundowicz; Piotr Milecki; Julian Malicki
Journal:  J Pers Med       Date:  2021-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.